Cargando…
Distribution and Protective Role of HLAB40 in Iranian Patients with Kawasaki Disease; a Report from Southern Iran
Objective: Kawasaki disease (KD) clinically presents as a systemic vasculitis syndrome with significant cardiovascular involvement. With different incidence among different ethnic groups, the role of certain human leukocyte antigens and their products has been considered as a crucial predisposing fa...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Tehran University of Medical Sciences
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4339557/ https://www.ncbi.nlm.nih.gov/pubmed/25755855 |
_version_ | 1782358880817250304 |
---|---|
author | Ajami, Gholamhossein Aflaki, Khashayar Alyasin, Soheila Gharesi-fard, Behrooz Borzouee, Mohammad Amoozgar, Hamid |
author_facet | Ajami, Gholamhossein Aflaki, Khashayar Alyasin, Soheila Gharesi-fard, Behrooz Borzouee, Mohammad Amoozgar, Hamid |
author_sort | Ajami, Gholamhossein |
collection | PubMed |
description | Objective: Kawasaki disease (KD) clinically presents as a systemic vasculitis syndrome with significant cardiovascular involvement. With different incidence among different ethnic groups, the role of certain human leukocyte antigens and their products has been considered as a crucial predisposing factor in the immune responses in this disease. Methods: We determined the distribution of human leukocyte antigens type B for 90 Iranian patients with Kawasaki disease in order to evaluate a possible association between these antigens and this disease in our area. We used the polymerase chain reaction (PCR) sequence specific primers (PCR-SSP) technique for antigen typing. Distribution of these antigens for 89 healthy Iranians used as control. Findings : While 7 (3.9%) of our patients were positive for human leukocyte antigen type B 40(*), there were 18 (10.1%) subjects from the control group who had this antigen with statistically significant difference between patients and control group (CI= 95%, RR=1.15 and P= 0.02). Data were analyzed by Pearson chi-square test and Fisher's exact test. SPSS version 15 was used for statistical analysis and a P value less than 0.05 considered statistically significant Conclusion: The presence of higher frequency of allele type-B40(*) in the control group may represent a protective role for this antigen with resultant decreased susceptibility to KD in our area. |
format | Online Article Text |
id | pubmed-4339557 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2014 |
publisher | Tehran University of Medical Sciences |
record_format | MEDLINE/PubMed |
spelling | pubmed-43395572015-03-09 Distribution and Protective Role of HLAB40 in Iranian Patients with Kawasaki Disease; a Report from Southern Iran Ajami, Gholamhossein Aflaki, Khashayar Alyasin, Soheila Gharesi-fard, Behrooz Borzouee, Mohammad Amoozgar, Hamid Iran J Pediatr Original Article Objective: Kawasaki disease (KD) clinically presents as a systemic vasculitis syndrome with significant cardiovascular involvement. With different incidence among different ethnic groups, the role of certain human leukocyte antigens and their products has been considered as a crucial predisposing factor in the immune responses in this disease. Methods: We determined the distribution of human leukocyte antigens type B for 90 Iranian patients with Kawasaki disease in order to evaluate a possible association between these antigens and this disease in our area. We used the polymerase chain reaction (PCR) sequence specific primers (PCR-SSP) technique for antigen typing. Distribution of these antigens for 89 healthy Iranians used as control. Findings : While 7 (3.9%) of our patients were positive for human leukocyte antigen type B 40(*), there were 18 (10.1%) subjects from the control group who had this antigen with statistically significant difference between patients and control group (CI= 95%, RR=1.15 and P= 0.02). Data were analyzed by Pearson chi-square test and Fisher's exact test. SPSS version 15 was used for statistical analysis and a P value less than 0.05 considered statistically significant Conclusion: The presence of higher frequency of allele type-B40(*) in the control group may represent a protective role for this antigen with resultant decreased susceptibility to KD in our area. Tehran University of Medical Sciences 2014-08 2014-05-24 /pmc/articles/PMC4339557/ /pubmed/25755855 Text en Copyright © 2014 by Pediatrics Center of Excellence, Children’s Medical Center, Tehran University of Medical Sciences, All rights reserved This is an Open Access article distributed under the terms of the Creative Commons Attribution License, (http://creativecommons.org/licenses/by/3.0/) which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Original Article Ajami, Gholamhossein Aflaki, Khashayar Alyasin, Soheila Gharesi-fard, Behrooz Borzouee, Mohammad Amoozgar, Hamid Distribution and Protective Role of HLAB40 in Iranian Patients with Kawasaki Disease; a Report from Southern Iran |
title | Distribution and Protective Role of HLAB40 in Iranian Patients with Kawasaki Disease; a Report from Southern Iran |
title_full | Distribution and Protective Role of HLAB40 in Iranian Patients with Kawasaki Disease; a Report from Southern Iran |
title_fullStr | Distribution and Protective Role of HLAB40 in Iranian Patients with Kawasaki Disease; a Report from Southern Iran |
title_full_unstemmed | Distribution and Protective Role of HLAB40 in Iranian Patients with Kawasaki Disease; a Report from Southern Iran |
title_short | Distribution and Protective Role of HLAB40 in Iranian Patients with Kawasaki Disease; a Report from Southern Iran |
title_sort | distribution and protective role of hlab40 in iranian patients with kawasaki disease; a report from southern iran |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4339557/ https://www.ncbi.nlm.nih.gov/pubmed/25755855 |
work_keys_str_mv | AT ajamigholamhossein distributionandprotectiveroleofhlab40iniranianpatientswithkawasakidiseaseareportfromsoutherniran AT aflakikhashayar distributionandprotectiveroleofhlab40iniranianpatientswithkawasakidiseaseareportfromsoutherniran AT alyasinsoheila distributionandprotectiveroleofhlab40iniranianpatientswithkawasakidiseaseareportfromsoutherniran AT gharesifardbehrooz distributionandprotectiveroleofhlab40iniranianpatientswithkawasakidiseaseareportfromsoutherniran AT borzoueemohammad distributionandprotectiveroleofhlab40iniranianpatientswithkawasakidiseaseareportfromsoutherniran AT amoozgarhamid distributionandprotectiveroleofhlab40iniranianpatientswithkawasakidiseaseareportfromsoutherniran |